Related Experiment Video
Updated: Feb 6, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Identification of potential core genes in triple negative breast cancer using bioinformatics analysis
Man-Xiu Li1, Li-Ting Jin1, Tie-Jun Wang1
1Department of Breast Cancer, Hubei Cancer Hospital, Wuhan, People's Republic of China, 39390822@qq.com.
Background:
Triple-negative breast cancer (TNBC) is a subtype of breast cancer with poor clinical outcome and limited treatment options. Lacking molecular targets, chemotherapy is the main adjuvant treatment for TNBC patients.
Materials And Methods:
To explore potential therapeutic targets for TNBC, we analyzed three microarray datasets (GSE38959, GSE45827, and GSE65194) derived from the Gene Expression Omnibus (GEO) database. The GEO2R tool was used to screen out differentially expressed genes (DEGs) between TNBC and normal tissue. Gene Ontology function and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis were performed using the Database for Annotation, Visualization and Integrated Discovery to identify the pathways and functional annotation of DEGs. Protein-protein interaction of these DEGs was analyzed based on the Search Tool for the Retrieval of Interacting Genes database and visualized by Cytoscape software. In addition, we used the online Kaplan-Meier plotter survival analysis tool to evaluate the prognostic value of hub genes expression in breast cancer patients.
Results:
A total of 278 upregulated DEGs and 173 downregulated DEGs were identified. Among them, ten hub genes with a high degree of connectivity were picked out. Overexpression of these hub genes was associated with unfavorable prognosis of breast cancer, especially, CCNB1 overexpression was observed and indicated poor outcome of TNBC.
Conclusion:
Our study suggests that CCNB1 was overexpressed in TNBC compared with normal breast tissue, and overexpression of CCNB1 was an unfavorable prognostic factor of TNBC patients. Further study is needed to explore the value of CCNB1 in the treatment of TNBC.
Insights
Triple-negative breast cancer (TNBC) has limited treatment options. This study identified CCNB1 as a potential therapeutic target, showing its overexpression is linked to poor outcomes in TNBC patients.
Area of Science:
- Oncology
- Genomics
- Bioinformatics
Background:
- Triple-negative breast cancer (TNBC) presents a significant clinical challenge due to its aggressive nature and limited targeted therapies.
- Current treatment for TNBC primarily relies on chemotherapy, highlighting the urgent need for novel therapeutic strategies.
- Identifying specific molecular targets is crucial for improving TNBC patient outcomes.
Purpose of the Study:
- To identify potential therapeutic targets for triple-negative breast cancer.
- To analyze gene expression profiles and identify differentially expressed genes (DEGs) in TNBC.
- To evaluate the prognostic significance of identified genes in breast cancer.
Main Methods:
- Analysis of three Gene Expression Omnibus (GEO) microarray datasets (GSE38959, GSE45827, GSE65194) using GEO2R.
- Functional and pathway enrichment analysis of DEGs via DAVID.
- Protein-protein interaction network construction using STRING and visualized with Cytoscape.
- Prognostic value assessment using the Kaplan-Meier plotter.
Main Results:
- Identification of 278 upregulated and 173 downregulated DEGs between TNBC and normal tissues.
- Ten hub genes with high connectivity were identified from the DEG analysis.
- Overexpression of these hub genes, particularly CCNB1, was significantly associated with unfavorable prognosis in breast cancer patients, especially in TNBC.
Conclusions:
- CCNB1 is significantly overexpressed in triple-negative breast cancer compared to normal breast tissue.
- Overexpression of CCNB1 serves as an unfavorable prognostic factor for TNBC patients.
- CCNB1 warrants further investigation as a potential therapeutic target for TNBC treatment.
More Related Videos
11:34Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
10:10Long-term Culture of Human Breast Cancer Specimens and Their Analysis Using Optical Projection Tomography
Published on: July 29, 2011
Related Concept Videos
The Nucleosome Core Particle
The paradox
Nucleosomes, paradoxically, perform two opposite functions simultaneously. On the one hand, their main responsibility is to protect the delicate DNA strands from physical damage and help achieve a higher compaction ratio. While on the other hand, they must allow polymerase enzymes to access DNA...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Negative Regulator Molecules
Cancer Survival Analysis
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Scalar and Vector Triple Products
The scalar triple product is the dot product of a vector with the cross product of two vectors....